Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN vs ANAGRELIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN vs ANAGRELIDE: Safety Overview

Metric AMPICILLIN ANAGRELIDE
Total FAERS Reports 3,653 1,336
Deaths Reported 482 131
Death Rate 13.2% 9.8%
Hospitalizations 1,227 580
Average Patient Age 45.1 yrs 69.6 yrs
% Female Patients 65.6% 58.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 18, 2005
Manufacturer Meitheal Pharmaceuticals Inc. ANI Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription